Combined statin-fibrate therapy-induced rhabdomyolysis: Case report
Introduction Rhabdomyolysis is a rare, but serious and potentially fatal adverse reaction of the statin application that may be developed in any time of therapy. It is characterized by massive destruction of muscles associated with the large increase of creatine kinase (CK) leading to myoglobinuria...
-д хадгалсан:
Үндсэн зохиолчид: | Jozić Tanja L. (Зохиогч), Terzić Branka M. (Зохиогч), Mitrović Predrag M. (Зохиогч), Kostić Jasminka D. (Зохиогч), Milanov Marko Z. (Зохиогч), Stojanović Milena M. (Зохиогч), Ašanin Milika R. (Зохиогч) |
---|---|
Формат: | Ном |
Хэвлэсэн: |
Srpsko lekarsko drustvo,
2014-01-01T00:00:00Z.
|
Нөхцлүүд: | |
Онлайн хандалт: | Connect to this object online. |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Mechanism of Statin-Induced Rhabdomyolysis
-н: Kazuho Sakamoto, зэрэг
Хэвлэсэн: (2013) -
The self-limiting nature of statin-induced rhabdomyolysis
-н: Abdulsalam A Al-Sulaiman, зэрэг
Хэвлэсэн: (2009) -
Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho Database
-н: Yohei Sobukawa, зэрэг
Хэвлэсэн: (2024) -
Hypolipidemic Mechanisms of Ananas comosus L. Leaves in Mice: Different From Fibrates but Similar to Statins
-н: Weidong Xie, зэрэг
Хэвлэсэн: (2007) -
Ascorbic Acid Significantly Decreases Creatine Kinase Plasma Levels in an Animal Model of Statin/Fibrate-Induced Myopathy
-н: Mohsen Zabihi, зэрэг
Хэвлэсэн: (2021)